Donas Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 13-12-2024
- Paid Up Capital ₹ 0.30 M
as on 13-12-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 1.18 Cr
as on 13-12-2024
- Satisfied Charges ₹ 1.00 M
as on 13-12-2024
- Revenue -10.55%
(FY 2020)
- Profit 28.61%
(FY 2020)
- Ebitda 38.49%
(FY 2020)
- Net Worth 41.65%
(FY 2020)
- Total Assets -11.03%
(FY 2020)
About Donas Drugs And Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.18 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sairam and Muthumuni Balan serve as directors at the Company.
- CIN/LLPIN
U74900TN2015PTC103157
- Company No.
103157
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Nov 2015
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Donas Drugs And Pharmaceuticals Private Limited offer?
Donas Drugs And Pharmaceuticals Private Limited offers a wide range of products and services, including HR & Payroll Outsourcing Services, Administrative Support Service.
Who are the key members and board of directors at Donas Drugs And Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sairam  | Managing Director | 03-Nov-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Muthumuni Balan | Additional Director | 01-Jun-2016 | Current |
Financial Performance of Donas Drugs And Pharmaceuticals.
Donas Drugs And Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 10.55% decrease. The company also saw a substantial improvement in profitability, with a 28.61% increase in profit. The company's net worth Soared by an impressive increase of 41.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Donas Drugs And Pharmaceuticals?
In 2020, Donas Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 06 Jun 2019 | ₹1.18 Cr | Open |
Canara Bank Creation Date: 03 Jun 2020 | ₹1.00 M | Satisfied |
How Many Employees Work at Donas Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Donas Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Donas Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Donas Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
